Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 7/20 | 0.65 |
| ▸ | NPC1 | O15118 | 5/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6948263 | 1.00 | RARB (0.65) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL14295767 | 1.00 | RARB (0.65) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL13029249 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL2774683 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL9636338 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL10342131 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL7910730 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL9436035 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL7121080 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL9241350 | 0.98 | RARB (0.63) | RARBRAB9ANPC1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160274084-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC | 2016-09-22 | — | — | US | disclosed |
| US-9341576-B2 | Detection of vapor phase compounds by changes in physical properties of a liquid crystal | PLATYPUS TECHNOLOGIES, LLC (US) | 2016-05-17 | — | — | US | disclosed |
| US-20160018371-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2016-01-21 | — | — | US | disclosed |
| US-9103794-B2 | Substrates, devices, and methods for quantitative liquid crystal assays | PLATYPUS TECHNOLOGIES LLC (US) | 2015-08-11 | — | — | US | disclosed |
| US-20140356970-A1 | Liquid crystal devices with mixed anion metal salts | NATIONAL SCIENCE FOUNDATION | 2014-12-04 | — | — | US | disclosed |
| US-20140313468-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2014-10-23 | — | — | US | disclosed |
| US-8512820-B2 | Organic ionic phenylpyrimidine compounds and displays formed thereof | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-20120319044-A1 | ORGANIC IONIC PHENYLPYRIMIDINE COMPOUNDS AND DISPLAYS FORMED THEREOF | CITIZEN FINEDEVICE CO., LTD. (JP) | 2012-12-20 | — | — | US | disclosed |
| US-20120288951-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC (US) | 2012-11-15 | — | — | US | disclosed |
| US-20120135450-A1 | SUBSTRATES, DEVICES, AND METHODS FOR QUANTITATIVE LIQUID CRYSTAL ASSAYS | PLATYPUS TECHNOLOGIES, LLC (US) | 2012-05-31 | — | — | US | disclosed |
| US-7795007-B2 | contacting sample with a peptide attachment surface to create a peptidized surface, contacting the peptidized surface with a recognition reagent that selectively binds or forms a complex with the post-translationally modified peptide to provide an incubated surface, contacting a liquid crystal | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-09-14 | — | — | US | disclosed |
| US-20080268546-A1 | DETECTION OF DNA HYBRIDIZATION ON SURFACES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319044-A1 | ORGANIC IONIC PHENYLPYRIMIDINE COMPOUNDS AND DISPLAYS FORMED THEREOF | PNP, PNPO, TYMP | RARB 1775/4885RAB9A 4681/4885NPC1 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.